Crispr gene-editing ‘revolution’ treats internal organ for first time
Crispr基因编辑“革命”首次被用于治疗内脏

US start-up co-founded by Nobel laureate marks breakthrough over therapies restricted to external cells
美国初创企业Intellia的早期试验数据标志着Crispr疗法取得突破，表